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Abstract
Viral and non-viral vectors have been developed for gene therapy, but their use is associated with unresolved problems of
efficacy and safety. Efficient and safe methods of DNA delivery need to be found for medical application. Here we report a
new monopolar system of non-viral electro-gene transfer into the thymus in vivo that consists of the local application of
electrical pulses after the introduction of the DNA. We assessed the proof of concept of this approach by correcting ZAP-70
deficient severe combined immunodeficiency (SCID) in mice. The thymic electro-gene transfer of the pCMV-ZAP-70-IRES-
EGFP vector in these mice resulted in rapid T cell differentiation in the thymus with mature lymphocytes detected by three
weeks in secondary lymphoid organs. Moreover, this system resulted in the generation of long-term functional T
lymphocytes. Peripheral reconstituted T cells displayed a diversified T cell receptor (TCR) repertoire, and were responsive to
alloantigens in vivo. This process applied to the thymus could represent a simplified and effective alternative for gene
therapy of T cell immunodeficiencies.
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Introduction
The thymus is the primary site of generation of functional T
lymphocytes. After maturation, T cells are released into the
bloodstream and lymph fluid and then migrate to secondary
lymphoid organs, mainly the spleen and lymph nodes. T
lymphocytes play a crucial role in adaptative immune responses
by recognizing antigens derived from pathogens or tumor cells.
Adaptative immune responses may be impaired in several ways,
including the natural mutations characterized by blocks in T cell
development that have been described in mice and humans. These
disorders are known collectively as SCIDs, because the clinical
consequence is a devastating predisposition to infections and
cancers. At least 9 different forms of human SCIDs have now been
recognized and can be grouped according to genes involved such
as cc, ADA, Artemis, ZAP-70, JAK-3, IL7Ra, CD45, RAG-1 and
RAG-2 [1]. Gene therapy appears to be an appealing treatment
by inserting corrective transgenes into abnormal cells [2].
Recombinant viruses are effective vectors for transferring genes
into haematopoietic precursors. However, the main limitations
reside in the possible development of opportunist cancers and in
the potential toxicity in peripheral lymphocytes of the gene
expression system controlled by retroviral long terminal repeats
(LTRs) [3].
Gene therapy thus requires more efficient alternative therapeu-
tic methods, using non-viral vectors in conjunction with an
effective and safe physical process. Applying an electric field to
cells and tissues significantly increases DNA uptake and gene
expression [4]. Electroporation is usually performed by locally
injecting DNA to the site of interest followed by the application of
an electrical field. In vivo, electroporation has been already
performed on several tissues, notably muscle and liver [5].
However, to our knowledge the thymus has never been
electrotransfected. Therefore, in vivo electroporation of thymus
appears to be a promising method to circumvent severe
immunodeficiencies. Classical processes are aggressive using
bipolar and even multipolar electrodes, often involving incisions,
and the success of gene transfer may be compromised by
aggressive surgical procedures [4].
Here, we describe a new method of electroporation without any
incision, using a monopolar device to target the thymus in vivo.W e
stably electro-gene transferred thymocytes during their maturation
in the thymus. We found the corresponding mature transfected T
lymphocytes correctly localized in T zones of lymph nodes and
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2059spleen one month following treatment. We evaluated the
usefulness of this approach to treat thymus-linked SCIDs using a
murine model of ZAP-70 deficiency. ZAP-70 is a protein tyrosine
kinase crucially involved in T cell differentiation. Its absence
results in a SCID phenotype with a block at the CD4
+CD8
+
double-positive early stage of differentiation [6]. ZAP-70 gene
transfer by in vivo thymic electroporation in ZAP-70
-/- mice results
in the reconstitution of CD4
+ and CD8
+ single-positive thymocytes
and the long-term detection of a high number of peripheral T
lymphocytes displaying a diversified TCR repertoire and normal
functional properties.
Results
A simple procedure to electroporate the thymus in vivo
The target organ is the mouse thymus. To transfect this deep
organ directly in vivo without surgical intervention, we developed
an electroporation procedure based on a monopolar device using
a single needle as anode to inject the plasmid DNA and apply the
electric field (Figure 1A). The needle size was calibrated
according to the animal size and thymus localization. On an
anaesthetized mouse, a crocodile clip corresponding to the
cathode, establishes skin contact on the paw opposite to the
injection site. We introduced the needle between the first and the
second rib keeping the angle of the needle at 45u from the
longitudinal axis (Figure 1A, inset). Thereafter, a volume of 10 ml
of highly concentrated plasmid DNA was slowly injected in one
thymic lobe and the current was immediately delivered. The
second lobe was then treated in the same way. This technique
allows electrotransfection of the thymus without affecting vital
proximal organs such as the heart and lung, since all mice
survived the intervention. Impact points on each thymic lobe
were observed following electroporation (Figure S1A). Therefore,
we established a safe simple procedure to electroporate the
thymus in vivo.
Optimization of electrical parameters
Previous in vivo electroporation analyses on the most widely
targeted tissue which is skeletal muscle have shown that an
effective conditions is 5 pulses of 1 Hz, at 100 msec, with 10 mg
of DNA [7]. Based on ‘‘muscle’’ parameters in combination with
different voltages ranging from 0 to 900 V, we determine the
optimal voltage to electrotransfect the thymus by transfecting the
pCMV-luciferase (pCMV-luc) expression vector (Figure 1B).
Maximal gene expression 24 hours after electroporation was
achieved at 300 V. The amount of luciferase was increased 30-
fold compared to the control condition (0 V). Moreover, we
confirmed the transfection efficacy by in vivo bioluminescence
(Figure S1B).
To assess whether these parameters result in a stable
transfection, we investigated luciferase expression one month after
injection or electroporation at 300 and 600 V of pCMV-luc
plasmid (Figure 1C). We observed a complete absence of luciferase
expression at 0 and 600 V. In contrast, at 300 V the luciferase
expression was still detected although decreased five fold relative
to 24 hours post-electroporation. This decrease can be partly
explained by two physiological processes of the thymus. Firstly, the
T cell maturation in the thymus takes about one month and
mature T lymphocytes then migrate towards secondary lymphoid
organs [8]. Secondly, approximately 90% of thymocytes are
eliminated by apoptosis during selection mechanisms [9].
Altogether, these results showed that the in vivo thymic electropo-
ration at 300 V leads to an efficient and stable transfection.
Differentiating thymocytes are transfected in vivo
We determined the distribution of transfected thymic cells by
confocal microscopy. 10 mg of pCMV-Enhanced Green Fluores-
cent Protein (EGFP) expression vector was injected or electropo-
rated at 300 V (Figure 2). Detailed observation of thymic sections
revealed no necrosis or any sign of tissue damage near the
injection site, suggesting that the procedure was well tolerated
(data not shown). As expected, sections of the non-injected
thymus exhibited no EGFP signal (Figure 2A). In contrast, after
24 hours, a weak uniform staining was observed at 0 V
(Figure 2B); while at 300 V the signal was stronger and numerous
clusters of transfected cells were visualized (Figure 2C). These
results were also confirmed by immunohistochemistry experi-
ments (Figure 2D). One month later, the level of transfected cells
strongly decreased, which is consistent with luciferase results
described above (Figure 2E, F). Moreover, transfected cells were
localized in several distinct clusters localized around venules of
the cortico-medullary region suggesting that transfected cells
could be thymocytes at the end stage of maturation on their way
to be exported to the periphery.
Three independent experiments were performed to confirm this
hypothesis, by co-staining lymphocytes using the CD3 marker
which labeled nearly the whole thymocyte populations (DN to SP).
We observed that 3.660.8% of T cells are transfected in the cortex
and 1.960.7% in the medulla 24 hours after electroporation
(Figure S2). After one month, we still detected 1.160.4% of T cells
in the medulla and at the cortico-medullary junction, but none in
the cortex. This observation is consistent with the fact that mature
thymocytes congregate near blood vessels to be exported to the
periphery [10].
To immunophenotype EGFP transfected thymocytes, we
analyzed EGFP expression within the four main thymocyte
subpopulations (CD4
2CD8
2 double-negative (DN), CD4
+CD8
+
double-positive (DP) stage, CD4
+CD8
2 and CD4
2CD8
+ single-
positive (SP) by flow cytometry after 24 hours (Figure 2G). We
found similar percentages of transfection obtained by confocal
microscopy (6.72% of DN, 2.82% of DP and 4.4% of CD4
+ and
CD8
+ SP cells). As expected, we did not observe any significant
transfection in the 0 V condition. Moreover, we deduced that
thymocytes in cell cycle may be preferentially transfected such as
DN thymocytes that undergo extensive proliferation [11] and SP
thymocytes that expand the newly selected T repertoire [12].
Finally, while thymocytes are difficult to transfect using a non viral
system, our method allows their transfection with reasonable
success, and the expression of the transfected gene is observed in
the main thymocyte subpopulations.
Transfected T cells are detected in secondary lymphoid
organs one month after in vivo thymic electroporation
To determine whether transfected thymocytes develop into
mature T cells, we analyzed spleen sections by two methods one
month after thymic electroporation (Figure 3). Numerous EGFP
cells were detected in the white pulp as shown by a DAPI
counterstaining in confocal microscopy (Figure 3A, B), and
confirmed by immunohistochemistry using an anti-EGFP anti-
body (Figure 3C). This observation is consistent with successful
transfection of thymocytes in the thymus, and shows that
transfected mature thymocytes were exported to the spleen.
Moreover, a detailed observation showed that some transfected T
cells are localized around a central arteriole suggesting that these
cells are fresh immigrants [13] (Figure 3B; inset). The same
analysis was also performed in lymph-nodes by labeling high
endothelial venules with the PNAd antibody that recognizes the
In Vivo Thymic Electroporation
PLoS ONE | www.plosone.org 2 April 2008 | Volume 3 | Issue 4 | e2059Figure 1. Monopolar electroporation of the thymus in anaesthetized mice. (A) Bold dotted lines indicate the angle of axis legs. The needle
(optimal size: 3 mm) is inserted between the two first ribs, under the ribcage, following the angle of the paw parallel to the benchtop. The
stimulating syringe, delivering electric pulses and plasmid DNA, represents the anodic electrode. The cathodic pole is represented by a crocodile clip
attached to the paw of the side opposite to the injection point. The inset represents a schematic representation of the needle insertion through the
ribcage to inject the thymus. (B) Luciferase activity in the thymus 24 hours after injection with or without electroporation. 10 mg of luciferase DNA
plasmid in a volume of 10 ml was injected into each thymic lobe of 10 mice for 0 V, 10 mice for 300 V and 5 mice for all other voltages. Whatever the
electric intensity applied, all mice survived. (C) Luciferase activity 24 hours (h) and one month after injection in the thymus without or with
electroporation at 300 and 600 V, respectively. Four mice were analyzed for each condition.
doi:10.1371/journal.pone.0002059.g001
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PLoS ONE | www.plosone.org 3 April 2008 | Volume 3 | Issue 4 | e2059Figure 2. Distribution and immunophenotype of EGFP transfected thymocytes in electroporated thymi. Sections of thymi that were: (A)
non injected; (B) injected without electroporation after 24 hours and (C) electroporated at 300 V after 24 hours were analyzed for the EGFP
expression signal by confocal microscopy. Each image was captured and processed under the same conditions with a 10X objective. (D) 20X view of
immunohistochemistry analysis using an anti-EGFP antibody of a thymus electroporated with the EGFP DNA plasmid at 300 V after 24 hours. (E) After
one month, a nuclear counterstain (DAPI, blue) shows that these transfected cells are localized around blood vessels near the cortico-medullary
junction (CMJ). (F) 20X view of immunohistochemistry analysis using an anti-EGFP antibody shows numerous transfected cells in the medulla after
one month. Arrows indicate the EGFP expression signal. Abbreviations: c=cortex, m=medulla, v=venule. (G) Thymocyte profile stained with CD4
and CD8 monoclonal antibodies was analyzed by flow cytometry after 24 hours thymic electroporation. The percentage of cells within each quadrant
is indicated. The different populations of thymocytes expressing EGFP protein in wild-type, 0 V and 300 V electroporated thymus were analyzed. The
percentage of EGFP transfected cells is indicated within the quadrant of each population.
doi:10.1371/journal.pone.0002059.g002
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incoming EGFP transfected T cells were found around venules.
These secondary lymphoid organs are organized in both T and
B cell zones. To ensure that transfected T cells had correctly
migrated into T cell zones, a co-staining analysis was performed
on spleen and lymph-nodes sections by using anti-B220 and anti-
CD3 antibodies to detect B and T cell areas, respectively
(Figure 3E). B cell areas were mostly EGFP negative while T
cell zones show numerous EGFP positive cells. We quantified the
number of EGFP transfected lymphocytes using the CD3 marker
and observed 1.060.2% of cells in lymph nodes and 1.560.2% in
the spleen (Figure 3F).
Consequently, T cells were stably electroporated in the thymus,
since significant numbers of transfected T lymphocytes were
Figure 3. Detection of EGFP positive T lymphocytes in T zones of the spleen and lymph-nodes one month after thymic
electroporation. (A) Fluorescence analysis at 100X view of a splenic internal region reveals EGFP positive cells. (B) A nuclear counterstain (DAPI,
blue) shows that these positive cells are localized in the white pulp. Insets represent a higher magnification at 400X view of the central arteriole area
(ca) where a cluster of EGFP positive cells is observed. (C) 100X view of spleen immunohistochemistry analysis using an anti-EGFP antibody shows the
distribution of transfected cells (arrows). (D) EGFP positive cells are localized near high endothelial venules (HEVs) stained with an anti-PNAd antibody
(red) in lymph-nodes. (E) Sections of lymph-nodes and the spleen were analyzed by confocal microscopy after staining with a B cell specific antibody
(B220) and an anti-CD3 antibody that specifically reacts with T lymphocytes. Multiple representative clusters of EGFP transfected cells were found
mainly in T zones of different lymph-nodes and spleen sections. (F) Percentages of EGFP transfected CD3 positive T lymphocytes present within T
zones of lymph-nodes and the spleen were calculated as described in methods. The mean percentage and the standard deviation of 3 individual
organs (n=3) were calculated. Abbreviations: wp=white pulp, rp=red pulp, ca=central arteriole, v=vessel.
doi:10.1371/journal.pone.0002059.g003
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lymphoid organs one month later.
Restoration of thymic development in ZAP-70
-/- mice
after electroporation
We assessed the usefulness of this new approach to correct a
thymus-linked immunodeficiency. We chose the murine model of
Zeta-chain (TCR) Associated Protein kinase (ZAP-70) deficient
SCID, which exhibits a relatively late block in T cell
development at the CD4
+CD8
+ DP stage [6,15]. We constructed
the mouse ZAP-70/internal ribosome entry site/enhanced GFP
(ZAP-70-IRES-EGFP) cassette under the transcriptional control
of the cytomegalovirus (CMV) promoter. In this context, ZAP-70
and EGFP expression is concordant. Thymi of ZAP-70
-/- mice
were electroporated with this expression vector at the optimal
voltage of 300 V with a pulse length of 20 ms because longer
pulse lengths improved transfection of muscle [16] as confirmed
by our results for this gene in the thymus (data not shown).
Transfection efficacy was evaluated after 48 hours by analyzing
levels of ZAP-70 mRNA and protein in total thymocytes by RT-
PCR and western-blot, respectively (Figure 4A, upper panel). As
expected, the ZAP-70 mRNA (left panel) and protein (right
panel) were clearly detected in wild-type (WT) thymocytes while
no expression was observed in ZAP-70
-/- thymocytes. In contrast,
total thymocytes from in vivo electroporated thymus expressed the
ZAP-70 transgene, albeit more weakly than the endogenous
protein in WT mice. ZAP-70 and EGFP ectopic expression were
further studied by determining their distribution pattern by
confocal microscopy (Figure 4A, lower panel). Numerous
transfected cells that co-expressed ZAP-70 and EGFP proteins
were detected in the thymus, confirming the successful
transfection.
We then assessed the capacity of this transfection to restore
thymocyte development. The CD4 and CD8 thymocyte profile
was analyzed in WT and in electroporated ZAP-70
-/- mice after
one and two weeks as well as in ZAP-70
-/- mice (Figure 4B). One
week after electroporation, 2.1% of CD4 SP and 0.7% of CD8 SP
were detected while after two weeks 5.8 and 4.4% were observed
for CD4 and CD8 SP thymocytes, respectively. These results
indicate that ZAP-70 expression driven from the electroporated
pCMV-ZAP-70-IRES-EGFP DNA plasmid is capable of correct-
ing the differentiation block in ZAP-70
-/- mice.
Restoration of thymocyte development in ZAP-70-/- mice
results in appearance of mature T cells in the periphery
In an attempt to determine whether in vivo gene transfer in ZAP-
70
-/- thymi results in the appearance of mature T cells in the
periphery, spleens were analyzed 3 weeks after thymic electropo-
ration for the presence of CD4
+ and CD8
+ T lymphocytes
(Figure 4C; upper panel). We detected considerable numbers of T
lymphocytes in electroporated mice, reaching 11 and 7% for CD4
and CD8 T cells, respectively. Moreover, the same samples were
also analyzed for the presence of CD3
+ T lymphocytes (Figure 4C;
lower panel). Similar results showing the appearance of a high
level of T cells (24.5%) in electroporated mice compared to ZAP-
70
-/- mice (3.7%) were obtained. Identical results were also
obtained in lymph nodes (data not shown). We observed by
confocal microscopy using an anti-CD3 antibody that a large
numbers of transfected T lymphocytes were detected specifically in
the splenic white pulp (Figure S3A, upper panel). These cells are
ZAP-70 positive, as shown by western blot analysis (Figure S3A,
lower panel). Moreover, we showed that newly generated T cells
exhibit a characteristic CD44
hi CD62
lo activated phenotype
occurring during T cell reconstitution of immunodeficient mice
(Figure S3B) as found by Adjali and all [17]. Altogether, these data
demonstrate that the correction in ZAP-70 expression by
electroporation results in the presence of mature T cells correctly
localized in the periphery.
T lymphocytes exhibit a diversed receptor repertoire in
reconstituted ZAP-70
-/- mice
To evaluate the quality of T cell repertoire in reconstituted mice,
weused a quantitative PCR methodthatallows real timemonitoring
of PCR product appearance according to its relative abundance. We
analyzed V alpha genes, which are highly expressed, such as V1, V2
and V3 and those that are less frequent, such as V5, V8, V14 and
V17 [18]. The relative abundance of the transcripts was normalized
to the CD3e transcript. As expected in ZAP-70
-/- thymic samples,
TCRVtranscriptproductswerenotdetectableorpresentinverylow
amounts (Figure 5A, upper panel) while in the spleen they were not
detected (Figure 5A, lower panel). Interestingly, in reconstituted
ZAP-70
-/- mice, all the TCRV transcripts tested were detected in
thymus or spleen (Figure 5A). Moreover, we analyzed the size of the
CDR3 of TCR transcripts for alpha chain in reconstituted mice,
which showed polyclonal T cell population expressing a wide TCR
repertoire as found in WT mice (Figure S4).
To monitor the persistence of T cells in reconstituted mice, we
analyzed the CD4 and CD8 profile in the thymus and spleen ten
months after thymic electroporation (Figure 5B). As expected, SP
thymocytes were not detectable anymore in the thymus (CD4
+:
0.7%; CD8
+: 0.1%) (Figure 5B, left panel) while both types of T
cells were still present in the spleen (CD4
+: 7.5%; CD8
+:7.4%)
exhibiting a diversified TCR repertoire (Figure 5B, right panel, C).
In addition, FACS analyses showed that TCR bearing Va2 and
several Vb (Vb5.1–5.2, Vb8.1–8.2 and Vb11) persist among
mature CD8 and CD4 splenic T cells eighteen months following
reconstitution (Figure 5D, S5). Representative FACS dot plots are
also shown in Figure S5.
This indicates that T lymphocyte populations produced after in
vivo thymic electroporation resulted from a wide variety of
transfected thymocytes, which underwent thymic selection to
generate a long-term diversified TCR repertoire.
T lymphocytes exhibit normal functional properties in
reconstituted ZAP-70
-/- mice
To evaluate in vivo the functionality of CD8 and CD4 T cells in
long-term reconstituted mice, mice were vaccinated with DNA
encoding the full-length ovalbumin (OVA) protein (Figure 6A, B).
The percentage of circulating T lymphocytes was evaluated in each
condition to monitor the persistence of T cells over sixteen months
in reconstituted mice (Figure 6A, upper panel). Three weeks later,
the anti-OVA CD8 response was analyzed on circulating T cells by
in vitro stimulation with a specific OT-I peptide. In sixteen months
reconstituted mice, CD8
+ T cells exhibit a capacitysimilar to WT to
produce IFN-c, reflectinga normal CD8response (Figure 6A, lower
panel). CD4
+ T cells functionality was evaluated by anti-OVA IgG
titration (Figure 6B). Sixteen months reconstituted mice produced a
similarantibodylevelasWTvaccinated mice,showingthatCD4
+T
cells have the capacity to give a cooperative help signal to B cells.All
together, these results indicate that both CD8 and CD4 T cells
possess normal functional properties.
To assess the capacity of the reconstituted C57/BL6 ZAP70
-/-
mice to mount an allogeneic immune response, wild type and
seven and sixteen month reconstituted mice were compared for
their ability to reject fully histoincompatible BALB/c skin grafts
(Figure 6C-I). The reconstituted mice rejected their allogeneic
In Vivo Thymic Electroporation
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-/- mice following in vivo thymic electroporation with the pCMV-ZAP-70-IRES-EGFP DNA
plasmid. (A) The upper panel shows ZAP-70 mRNA (left panel) and protein (right panel) levels in total thymocytes from WT, in vivo electroporated
thymus at 300 V after 48 hours and in ZAP-70
-/- deficient mice assessed by RT-PCR and western-blot, respectively. The lower panel shows the
distribution of ZAP-70 and EGFP proteins analyzed 48 hours after in vivo electroporation of the pCMV-ZAP-70-IRES-EGFP DNA plasmid by confocal
microscopy (upper panel, 100X view). A higher magnification of transfected thymocytes is also presented (400X view). (B) Thymocyte profiles stained
with CD4 and CD8 monoclonal antibodies were analyzed in WT and ZAP-70
-/- mice electroporated at 300 V with the pCMV-ZAP-70-IRES-EGFP DNA
plasmid after one and two weeks as well as in ZAP-70
-/- mice. (C) three weeks after thymic electroporation, the presence of splenic T cells was
monitored using CD4 and CD8 monoclonal antibodies (upper panel). Percentages of CD4
+ and CD8
+ T lymphocytes from WT and reconstituted mice
as well as ZAP-70
-/- mice are indicated. The CD3
+ T lymphocytes profile was also analyzed by using a CD3 monoclonal antibody (lower panel). The
percentages of positively stained cells are indicated in each histogram.
doi:10.1371/journal.pone.0002059.g004
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PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e2059Figure 5. TCR repertoire diversity in ZAP-70
-/- electroporated mice. (A) Quantification of TCR V alpha transcripts in thymi and spleens
between WT, untreated ZAP-70
-/-, and ZAP-70
-/- mice electroporated at 300 V. Two and three weeks after electroporation, thymic (upper panel) and
splenic (lower panel) cDNAs were respectively amplified using oligonucleotides specific for CD3e and for a set of oligonucleotides specific for each of
the V alpha genes in conjunction with a primer specific of the constant region of TCR alpha chain. Histograms correspond to a representative
amplification of two separate experiments. (B) Thymocyte profile stained with CD4 and CD8 monoclonal antibodies was analyzed by flow cytometry
after 10 months thymic electroporation (left panel). The persistence of CD4 and CD8 T lymphocytes in the spleen was monitored by flow cytometry
10 month after thymic electroporation (right panel). (C) Quantification of TCR V alpha transcripts in spleens between WT, untreated ZAP-70
-/-, and
ZAP-70
-/- mice with thymi electroporated at 300 V after 10 months. Splenic cDNA was amplified using oligonucleotides specific for CD3e and for a set
of oligonucleotides specific for each of the V alpha genes in conjunction with a primer specific of the constant region of TCR alpha chain. Histograms
correspond to a representative amplification of two separate experiments. (D) TCRVa2 and indicated TCRVb usage by splenic CD8 and CD4 T cells was
evaluated by FACS analysis in eighteen month reconstituted mice compared to age-matched WT mice. Abbreviations: wks=weeks, mo=months.
doi:10.1371/journal.pone.0002059.g005
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PLoS ONE | www.plosone.org 8 April 2008 | Volume 3 | Issue 4 | e2059Figure 6: In vivo responsiveness of reconstituted T lymphocytes in reconstituted ZAP
-/- mice. One year old reconstituted mice were
vaccinated with a plasmid encoding for the full length OVA. (A) The percentage of circulating T lymphocytes was evaluated in each indicated
condition (upper panel) to monitor the long-term persistence of T cells in reconstituted mice. The function of CD8
+ T cells was assessed by an antigen
presentation assay of OT-I peptide and the percentage of produced IFN-c was determined by intracellular FACS staining (lower panel). (B) The CD4
+ T
cell response following immunization was indirectly evaluated by measuring the level of anti-OVA IgG produced in reconstituted vs. WT mice (right
panel). (C-I) Reconstituted C57BL/6 ZAP
-/- mice rapidly rejected fully MHC-mismatched BALB\c skin grafts. (C) Survival curves for allogeneic BALB/c
skin grafts on C57BL/6 seven and sixteen months following reconstitution ZAP
-/- recipients (N) show rejection between day 10 and day 14, as fast as
the allogeneic control (#). However, survival curves for syngeneic C57BL/6 skin grafts are similar in both the C57BL/6 WT (X) and the untreated
ZAP
-/- recipients (n) to allogeneic BALB/c skin grafts on untreated ZAP-70
-/- mice (.), which don’t show any graft rejection. Histological sections were
performed of syngeneic (C57BL/6) skin that was grafted on WT C57BL/6 recipients (D, G) and allogeneic (BALB/c) skins which were grafted on a seven
months electroporated ZAP
-/- recipient (E, H) and on an untreated ZAP
-/- recipient (F, I). These sections have been analyzed by hematoxylin-eosin (H/
E, 200X view), to observed the presence of infiltrating cells (G, H, I), and by immunofluorescence (100X view), using antibodies against the epithelial
marker Keratin 5 (K5, green) and the T lymphocyte marker CD3, to characterize these infiltrating cells (D, E, F). Contrary to the non-rejected skins (D,F ,
G, I) harvested 100 days after transplantation, the dermis of BALB/c allogeneic skin graft rejected at 50% by the reconstituted C57BL/6 ZAP70
-/-
recipient contains numerous infiltrating cells (dark purple staining; H), characterized as CD3
+ cells (E). TCR Van specific primer with a specific TCR
constant alpha primer=ADVn
doi:10.1371/journal.pone.0002059.g006
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(Figure 6C). Histological examination of rejected skin allografts
revealed a marked difference between the seven month reconsti-
tuted C57/BL6 ZAP-70
-/- (Figure 6E, H) and untreated ZAP-70
-/-
recipients (Figure 6F, I) as well as the syngeneic control (Figure 6D,
G). Indeed, infiltration of CD3
+ cells in the skin dermis were found
in the former but were virtually absent in the latter. Thus, the
reconstituted C57/BL6 ZAP70
-/- are able to develop an allogeneic
response comparable to wild-type C57/BL6 mice. We can
conclude that reconstituted C57BL/6 ZAP
-/- mice possess T
lymphocytes with normal in vivo functional properties, enabling
them to respond to an OVA DNA vaccine and rapidly reject fully
MHC-mismatched BALB/c skin grafts.
Discussion
Various methods based on the use of viruses as biological
vectors have been developed over the years for the delivery of
DNA. However, after decades of research and development, gene
therapy still lacks a safe and efficient method permitting DNA
delivery. The use of electric pulses to deliver in vivo therapeutic
molecules to organs has seen rapid development over the last few
years and represents an increasingly attractive non-viral method.
The exponential increase in number of publications on the subject
over the last 10 years testifies to this interest. By using
bibliographic resources, using electroporation and gene therapy
as key words, we found that electrotransfer has been applied to all
easily accessible organs and also to internal organs when combined
with surgery [19]. However, the thymus, the primary lymphoid
organ in which several natural mutations have been characterized
to induce a blockage in T cell development, has never been
targeted by electro gene delivery for gene therapy.
The thymus is the organ in which haematopoietic precursors
develop into competent T lymphocytes. To correct immunodefi-
ciencies linked to natural mutations, transducing the therapeutic
gene with a retroviral vector into hematopoietic stem cells (HSCs)
has provided a proof of concept for gene therapy. However,
because vectors are composed of retroviral portions including the
LTR sequence that can activate additional viral sequences present
in the vector, the development of alternative methods has been
encouraged [2,3,20].
The method of electroporation we develop herein is based on a
monopolar device to target the thymus in vivo without any incision.
The classical procedure is simplified for two reasons: first, a single
electrified needle is used to inject the plasmid and apply the
electrical field, and second no surgical intervention is required.
The method is also simpler and more economical than viral
approaches. It allows the reduction of risks because only DNA is
electrotransferred into the thymus. The electrical parameters that
we defined lead to the targeting of thymocytes at various stages of
differentiation. It has been shown that dividing cells are highly
transfectable compared to quiescent ones, suggesting that DNA
enters the nucleus upon the disassembly of the nuclear envelope
during mitosis. Therefore, synchronizing the electrotransfer
protocol with mitosis has been shown to improve gene delivery
[21–23]. In our case, we do not need to synchronize since
thymocytes are continuously in cell cycle. This biological process
increases the efficiency of thymocyte electroporation within the
thymus. Thus, these encouraging results led us to investigate the
usefulness of this method for correcting T cell combined
immunodeficiencies as proof of concept.
The efficacy of this approach is in large part due to the
reconstitution of a SCID phenotype where thymocyte develop-
ment is blocked at the CD4
+CD8
+ double-positive stage [6]. We
demonstrated that a direct electroporation of the ZAP-70 gene
into thymi of ZAP-70
-/- mice allows effective and rapid T cell
reconstitution. Only two weeks later, CD4 and CD8 SP thymocyte
differentiation occurred and significant numbers of T lymphocytes
were present in the spleen and lymph nodes. Then, this non-viral
approach achieved with nonsurgical intervention resulted in a
significantly enhanced T cell reconstitution due to the direct
targeting of the thymus. This observation is consistent with two
recent studies which showed that intrathymic injection of either a
ZAP-70 expressing lentiviral vector or WT HSCs enhances the
kinetics of reconstitution [17,24].
The efficacy of reconstitution by our method is also characterized
in periphery by the detection of significant numbers of CD4 and
CD8 T lymphocytes that exhibit a diverse TCR repertoire. The
TCR repertoire observed in the reconstituted mice is characterized
by a large pool of both alha and beta chains, although some discrete
differences in the uses of V regions are observed in comparison to
wild type mice. For instance in 10 months old reconstituted mice,
Va1 and Va5 were not detected, and Vb11 appeared under
represented. The balance of the V uses in the repertoire is regulated
during the ontogeny of the thymus [25,26]. In as much as the
transfection is carried out in young adult mice, thus later than the
first steps of TCR alpha rearrangement in the thymus of wild type
mice, the difference observed in the use of V genes in reconstituted
mice may reflect changes in the regulation of TCR rearrangement
and expression. Whatever the relative frequencies of the various V,
the high degree of junctional variability at the CDR3 provides
enough diversity to restore a fully functional TCR repertoire.
Obviouslyinthis model wherethymocytedevelopmentis blocked at
the DP stage, only transfected T lymphocytes can migrate and be
functional at the periphery. Over the long-term, a peripheral
partially diversified TCR repertoire was sufficient to provide
functional T cells that mount in vivo immune responses to skin
allografts and this response is specific to the alloantigens
encountered (data not shown). Moreover, we monitored the
persistence of long-lived T cells in periphery more than sixteen
monthsafterthymicelectroporationandverifiedthatbothCD8and
CD4 T cells respond properly to an OVA DNA vaccine. Our data
suggest that T cells persist for long periods in the periphery after
their reconstitution by electro-gene transfer.
It is also important to note that the electroporation does not
impair a normal immune response, as shown by this study and as
well as by previous work on in vivo electroporation of splenic T
lymphocytes [27]. However, the safety of gene transfer by
electroporation in terms of potential insertional mutagenesis
remains to be fully investigated [28]. We propose that thymic
electroporation represents an interesting method for immunode-
ficiency gene therapy, which evidently requires optimization for
clinical application, such as a systematic study to identify the
optimal electropulsing sequence, injection periodicity and the ad
hoc device for human electro-gene transfer.
We believed that this study is an exciting proof-of-principle that
may advance the field of nonviral gene therapy. In addition,
electrotransfer may also be used to efficiently deliver to the thymus
a wide range of potentially therapeutic agents in addition to DNA,
including proteins, oligonucleotides and siRNAs. An important
feature of the monopolar electro-gene transfer resides in its
potential application to other deep organs without surgery.
Materials and Methods
Mice
C57/BL6 WT (Iffa Credo), BALB/c WT (Charles River) and
C57/BL6 ZAP-70
-/- (The Jackson Laboratory) [6] mice were bred
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experiments were done in agreement with the French and
European ethical rules. Thymic in vivo electro-gene transfer was
performed at 3–6 weeks of age. Forty and twenty C57/Bl6 mice
were transfected with pCMV-luc and pCMV-EGFP constructs,
respectively. After 24 hours a subset of mice was sacrificed, thirty
for the pCMV-luc and five for pCMV-EGFP for short term
analysis, the other mice were sacrificed after one month for long-
term analysis. T cell reconstitution experiments in ZAP-70
-/- mice
were performed in five independent assays including at least five
mice.
Expression plasmids
Two expression vectors containing the cytomegalovirus (CMV)
promoter inserted upstream of the coding sequence of the firefly
luciferase (Promega), and enhanced green fluorescent protein
(Clontech laboratories) were used for the optimization of electrical
parameters. For T cell reconstitution experiments, the pCMV-
ZAP-70 plasmid (kindly provided by AM Lellouch; CIML,
Marseille, France) was used to insert the ZAP-70 gene into the
pCMV-IRES-EGFP (Clontech laboratories). Each plasmid was
amplified in DH5a bacteria andpurified on Qiagen columns by
the lipopolysaccharide free method (Qiagen). A plasmid concen-
tration of 5 mg/ml was maintained as a stock in 0.9% NaCl. The
National Center for Biotechnology Information (NCBI) unigene
cluster IDs (http://www.ncbi.nlm.nih.gov) for the ZAP-70 gene
mentioned in the text is Mm.8038.
Electroporation procedures
Animals were anaesthetized by intraperitoneal injection with a
mixture of ketamine (100 mg/kg body weight; Imalgene 500;
Rhone-Merieux) and xylazine (10 mg/kg body weight; Rompun
2%; Centravet). A 10 ml formulation containing 10 mg of pCMV-
luc or pCMV-EGFP DNA was injected with an insulin syringe in
each thymic lobe and the current was immediately delivered, with
a standard square wave electroporator BTX T820 (BTX, Inc). 10
mg of DNA was tested with various values of voltage (0–900 V) and
5 pulses of 100 msec. For T cell reconstitution experiments, a 10 ml
formulation of 30 mg of pCMV-ZAP-70-IRES-EGFP DNA was
injected in each thymic lobe and then an electrical current of 5
pulses of 20 ms at 300 V was immediately applied. At the end of
the experiment the animals were kept warm until recovery.
Thymic protein extraction and luciferase assay
The thymus was recovered and homogenized in 0.5 ml of lysis
buffer (Promega) and centrifuged 10 min at 11000 rpm. Then, the
supernatant was assayed for total proteins and luciferase activity
with the luciferase assay kit from Promega for the measurement of
light production during 10 sec interval in a TD20 luminometer
(Turner design). The level of luciferase expression was quantified
using commercial luciferase from Photinus pyralis (Boehringer-
Mannhein).
Bioluminescence imaging
BALB/c mice were anesthetized with 4% isofluorane before the
intraperitoneal injection of 125 mg/kg body weight of luciferin
(sodium salt; Promega). Ten minutes after the luciferin injection,
photons emitted from luciferase within the animal and transmitted
through its tissues were collected and integrated for a 5 min period
images acquired using the NightOWL LB 981 CCD camera
(Berthold Technologies GmbH & Co). Pictures were taken, onto
which the pseudocolor image representing the spatial distribution
of the detected photons was superimposed. The signal intensities
from manually derived regions of interest (ROI) were obtained
and data were expressed as photon flux (counts/s). Background
photon flux was defined from a ROI of the same size placed in a
non luminescent area nearby the animal and then subtracted from
the measured luminescent signal intensity.
Immunofluorescence
To identify the distribution and cells expressing the transfected
gene, sections of 8 mm were prepared by cryosectioning after
embedding the organs in OCT (Sakura Finetech) and mounted on
glass slides. Sliced samples were kept in a humidified chamber and
were not allowed to dry during staining. Sections were fixed with
4% paraformaldehyde (Sigma Aldrich) in phosphate buffer for one
hour. Frozen sections were stained with anti-B220 hybridomas
(RA6-6B2), anti-CD3 hybridomas (OKT3) (kindly provided by
Dr. B Malissen, CIML, Marseille, France), unconjugated anti-
peripheral LN addressin (PNAd) antibody (MECA-79) (Pharmin-
gen) and anti-ZAP-70 (Santa Cruz biotechnology). Alexa 546–goat
anti–rat IgG and Alexa 546–goat anti-rabbit (Molecular Probes)
were used as secondary antibodies. As negative control, WT
thymus, spleen and lymph-nodes were used in all experiments.
Tissues were counterstained with 49,6 9-diamidino-2-phenylindole
(DAPI) at 1 mg/ml and mounted with Mowiol fluorescent
mounting medium (Calbiochem). Skin sections were also stained
with the anti-CD3 hybridomas (OKT3) and the anti-keratin 5
(AF138; Covance Research, Berkeley, CA).
Microscopy and Digital Imaging
Fluorescent images were acquired by a Zeiss LSM 510 confocal
microscope with a 515–525 nm bandpass filter set to view EGFP,
a 560 nm longpass filter set to view alexa 546 and a 420 nm
longpass filter set to view DAPI. All images were exposed using the
same exposure time under the same magnification. Quantitative
analysis of transfected cells distribution into thymus and secondary
lymphoid organ sections was performed using ImageJ software
(National Institutes of Health, Bethesda, Md) [29].
Immunohistochemistry
Dessicated frozen sections were fixed with 4% paraformalde-
hyde (Sigma Aldrich) in phosphate buffer for one hour.
Immunohistochemistry analysis was performed using the rabbit
ABC staining system (Santa Cruz Biotechnology). Endogenous
peroxidase activity was quenched by incubating slides for 10 min
in 1% hydrogen peroxide diluted in deionized H20. Sections were
incubated for one hour in 1.5% blocking serum in PBS for
blocking non-specific binding performed before antibody incuba-
tion. Rabbit anti GFP polyclonal antibody (BD Biosciences)
incubation was performed for 30 min at room temperature.
Single-color histochemical detection was performed using an
avidin-peroxidase conjugate system, and the antibody-enzyme
complex was visualized with 3939-diaminobenzidene (DAB).
Incubation times were carefully monitored to prevent saturation,
thus favoring visualization of differences in expression levels.
Sections were counterstained using Mayer’s hematoxylin solution
(Sigma Diagnostics), dehydrated through graded ethanol and
cover slipped using Eukitt mounting medium (Sigma Aldrich) for
examination. Skin sections were also counterstained using
hematoxylin-eosin solutions. Images were taken using Zeiss,
axiophot 2 microscope with Nikon digital camera DXm1200.
Flow cytometry
One to two million thymocytes were first incubated with the
2.4G2 hybridoma supernatant to block nonspecific binding of
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PE-labeled CD4 and APC-labeled CD8 mAbs (BD Pharmingen).
Viable cells were examined using a FACScalibur flow cytometer
and data analyzed with Cell Quest software (Becton Dickson). For
intracellular IFN-c staining, blood cells stimulated overnight with
OT-I OVA peptide (chicken OVA peptide 257–264 SIINFEKL)
were first stained for PE-labeled CD4 and PerCP-labeled CD8
mAbs (BD Pharmingen) surface markers, followed by fixation in
BD Cytofix/Cytoperm (BD biosciences). Staining was then
performed with APC-conjugated anti-IFN-c Ab (BD Biosciences)
in 1X BD Perm/Wash buffer. Cells were washed in 1X BD Perm/
Wash buffer twice before resuspension in FACS buffer and
analysis. For the repertoire analysis, PE-labeled TCRVa2,
TCRVb5.1–5.2, 8.1–8.2 and 11 were used in combination with
PerCP-labeled CD8 and APC-labeled CD4 antibodies (BD
Pharmingen).
RT-PCR
Total RNA was purified using TRIzol reagent (Gibco-BRL).
Single-strand cDNA was synthesized by reverse transcription on
0.3–5 mg of total RNA using oligo(dT)25 and SuperScript II
(Gibco-BRL) in a final volume of 20 ml. PCR reaction was
performed in a PTC 200 Peltier Thermal Cycler (MJ research Inc)
using 2 ml of the RT reaction product in a final volume of 50 ml,
using the following conditions: 94uC for 3 min (1 cycle), 30 cycles
of 94uC for 30 s, 66uC for 40 s, 72uC for 1 min, and 72uC for
10 min (1 cycle). Of the amplification product, 10 ml were resolved
on a 1% agarose gel. The sequence primers used to detect
specifically ZAP-70 are: forward primer: 59-GCACATATG-
CACTGTCCCTGGTCTA-39 and reverse primer 59-
GGGTCGCTGTAGGGACTCTCGTACA-39 while EGFP was
amplified with forward primer: 59-AGTCCAAAGGCA-
GAGCCCCA-39 reverse primer 59-CGCTGTCACCTTC-
GAGGTTA-39 and the housekeeping gene GAPDH with forward
primer: 59-AACGACCCCTTCATTGAC-39 and reverse primer
59-TCCACGAC ATACTCAGCAC-39.
Western-blots
To analyze the protein expression of ZAP-70, thymi and spleens
were crushed and cytosolic proteins of T cells were isolated by
using the Nuclear Protein Extraction Kit (Panomics). Protein
concentrations were measured using the Pierce BCA protein assay.
Samples were electrophoresed on 10% SDS-polyacrylamide gel
and transferred to Nitrocellulose membranes (BioRad) following
incubation with the rabbit polyclonal anti-ZAP-70 or the mouse
polyclonal anti-b-tubulin (Santa Cruz biotechnology). Proteins
were visualized using horseradish peroxidase-conjugated second-
ary antibody (Amersham Pharmacia Biotech,) and the enhanced
chemiluminescence detection system (Pierce).
Real time PCR
Total RNA from thymus or spleen samples was isolated using
TRIzol reagent. Reverse transcription was done with SuperScript
II RNase H
2 kit (Life Technologies) according to the manufac-
turer’s instructions. Each sample was tested for G3PDH as a
housekeeping gene, for CD3e to determine T lymphocyte levels
and for several T cell receptor variable alpha genes (TCRV) to
evaluate the diversity of T cells. PCR of cDNA sample was carried
out on a Light Cycler apparatus (Roche Diagnostics) under the
following conditions: 95uC 10 min, 30 cycles (95uC 15 sec, 59uC
10 sec, 72uC 15 sec). The amplification efficiencies of the different
PCR reactions were determined as described
27. The values for the
yield ranged from 85 to 87% among the different primer
combinations. Melting curves of PCR products were determined
according to the manufacturer’s instructions (Roche Diagnostics).
The specificity of the unique amplification product was established
by melting curve analysis and by migration on agarose gels. Each
sample was analyzed in duplicate in separate experiments. For
CDR3 length distribution, TCRValpha1 diversity analysis was
done using a TCR VA1 specific primer together with a specific
TCR constant alpha primer as described
27. Run off extensions
were performed with the following internal TCR constant alpha
specific fluorescent anti-sense primer (59CCATGGAATCTG-
GAACGTTCATC39).
Immunization and ELISA techniques
For DNA vaccination, mice were immunized in inguinal lymph
node [30] with 10 mg of plasmid pDNK-OVA encoding the full-
length OVA (kindly provided by Dr. P. Schuler). Plastic plates with
96 flat-bottomed wells were coated overnight at 4uC with 10 mg/
ml of OVA to allow for the selective detection of high-affinity,
OVA-specific IgG antibodies in the tested sera. Plates were
washed with PBS, 0.05% Tween-20 and then blocked with 1%
BSA+5% sucrose. After washing, dilutions of the test sera were
added and incubated overnight at 4uC. Bound antibody was
detected using anti-mouse gamma specific Alkaline phosphatase
conjugated IgG (Amersham Pharmacia Biotech). Plates were
developed with p-nitrophenyl-phosphate (Sigma-Aldrich), and
absorbance was read at 405 nm.
Skin grafting
Grafting tailskinonto theleftflank of recipients was performed as
previously reported [31,32]. Briefly, skin grafts of approximately
1 cm diameter were prepared from tails of female mice and grafted
ontotheflanksoffemalerecipientsaccordingtoanadaptationofthe
method of Billingham and Medawar [33]. Petroleum gauze was
placed over the graft, and sticking plaster was applied around the
trunk. The bandages were removed after 10 days, and the grafts
were monitored daily until day 30 and then every 2 days. Control
syngeneic grafts (C57BL/6 donor skin on C57BL/6 recipient)
always remained in excellent condition for more than 100 days.
Supporting Information
Figure S1 Analysis of the thymus after monopolar electropora-
tion. (A) The picture shows the healthy physical state of vital
organs close to the thymus after injection and electroporation.
Impact points in each thymic lobe are indicated by arrows. T:
Thymus, H: Heart and L: Lung. The pCMV-luc plasmid was
injected (0 V) or electroporated at 300 V and the luciferase
expression was analyzed 24 hours later. In vivo bioluminescence
indicated clear expression localized at the thymic site level. (B)
Representative bioluminescence imaging of a mouse with an in
vivo electroporated thymus with a luciferase DNA plasmid at
300 V in comparison to the 0 V condition. Levels of luminescence
are indicated by false colors on a scale of 0 to 6000 units.
Found at: doi:10.1371/journal.pone.0002059.s001 (1.47 MB TIF)
Figure S2 Efficacy of thymocyte transfection after in vivo thymic
electroporation. (A) Characterization of transfected cells by co-
staining analysis with an anti-CD3 antibody in the thymus
24 hours and one month after thymic electroporation. Insets
correspond to a higher magnification of EGFP transfected CD3
positive thymocytes. (B) The histogram shows percentages of
EGFP transfected CD3+ thymocytes present within the cortex and
the medulla 24 hours after electroporation and in the medulla/
CMJ one month later. The mean percentage and standard
deviation of 3 individual thymi (n=3) were calculated.
Found at: doi:10.1371/journal.pone.0002059.s002 (2.32 MB TIF)
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reconstituted ZAP-70-/- mice. (A) The presence of EGFP T
lymphocytes in reconstituted ZAP-70-/- mice was analyzed on
splenic sections using a CD3 monoclonal antibody by confocal
microscopy (upper panel). A nuclear counterstain (DAPI, blue)
shows that transfected T lymphocytes are correctly localized in the
white pulp (200X view). A higher magnification of transfected T
lymphocytes was also presented (630X view). The lower panel shows
a Western blot analysis of ZAP-70 protein levels in total thymocytes
from spleens in WT, ZAP-70-/- deficient mice and in two weeks
electroporated mice at 300 V (B) The phenotype of T lymphocytes
was determined by using anti-CD62L and CD44 antibodies. The
percentage of positively stained cells is indicated in each histogram.
Found at: doi:10.1371/journal.pone.0002059.s003 (2.63 MB TIF)
Figure S4 The sizes of the CDR3 were analysed by PCR
followed by gel electrophoresis. The figure displays representative
experiments of the CDR3 analysis of TCR transcripts for alpha
chain bearing Valpha1. The relative intensity of the bands (y axis)
was plotted as a function of the migration time in the
electrophoresis (x axis) which is proportional to the size of
CDR3. In each profile, the peaks corresponding to the reading
frame are indicated. In WT, the spectral distribution of the sizes is
representative of polyclonal composition of the TCR Valpha1
transcripts. In ZAP-70 deficient mice, no TCR transcripts are
found in the spleen, whereas a few peaks of TCR Valpha1
transcripts are detected in the thymus, which are issued from non
productive transcription known to take place in these mice. After
electroporation of ZAP-70 plasmid (ZAP-70-/- 300 V), TCR
transcripts bearing 1aV are detected in the thymus as well as in the
spleen. The spectral distributions of the CDR3 sizes are, and on
the one hand, similar in the thymus and the spleen of ZAP-70-/-
300 V electroporated mice, and on the other similar for WT and
ZAP-70-/- 300 V electroporated mice. Thus, ZAP-70-/- 300 V
electroporated mice are reconstituted with a polyclonal population
of T cells which expressed a wide repertoire of TCR.
Found at: doi:10.1371/journal.pone.0002059.s004 (0.61 MB TIF)
Figure S5 Representative dot plots of TCRVa2 and indicated
TCRVb usage in splenic CD8 and CD4 T cells populations.
Found at: doi:10.1371/journal.pone.0002059.s005 (1.57 MB TIF)
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